These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2306878)
1. Interleukin 1 enhances the development of spontaneous arthritis in MRL/lpr mice. Hom JT; Cole H; Bendele AM Clin Immunol Immunopathol; 1990 Apr; 55(1):109-19. PubMed ID: 2306878 [TBL] [Abstract][Full Text] [Related]
2. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. Hom JT; Bendele AM; Carlson DG J Immunol; 1988 Aug; 141(3):834-41. PubMed ID: 3260913 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Hom JT; Cole H; Estridge T; Gliszczynski VL Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):56-65. PubMed ID: 1728980 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs. Hom JT; Gliszczynski VL; Cole HW; Bendele AM Agents Actions; 1991 Jul; 33(3-4):300-9. PubMed ID: 1950817 [TBL] [Abstract][Full Text] [Related]
5. Complete Freund's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice. Ratkay LG; Zhang L; Tonzetich J; Waterfield JD J Immunol; 1993 Nov; 151(9):5081-7. PubMed ID: 8409458 [TBL] [Abstract][Full Text] [Related]
6. Polyarthritis in MRL-lpr/lpr mice: mouse type II collagen is antigenic but not arthritogenic. Boissier MC; Texier B; Carlioz A; Fournier C Autoimmunity; 1989; 4(1-2):31-41. PubMed ID: 2491640 [TBL] [Abstract][Full Text] [Related]
7. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice. Ratkay LG; Tait B; Tonzetich J; Waterfield JD J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961 [TBL] [Abstract][Full Text] [Related]
8. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903 [TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. Weinberg JB; Granger DL; Pisetsky DS; Seldin MF; Misukonis MA; Mason SN; Pippen AM; Ruiz P; Wood ER; Gilkeson GS J Exp Med; 1994 Feb; 179(2):651-60. PubMed ID: 7507509 [TBL] [Abstract][Full Text] [Related]
10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
11. A proinflammatory role for Fas in joints of mice with collagen-induced arthritis. Tu-Rapp H; Hammermüller A; Mix E; Kreutzer HJ; Goerlich R; Köhler H; Nizze H; Thiesen HJ; Ibrahim SM Arthritis Res Ther; 2004; 6(5):R404-14. PubMed ID: 15380040 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766 [TBL] [Abstract][Full Text] [Related]
13. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Lemay S; Mao C; Singh AK Kidney Int; 1996 Jul; 50(1):85-93. PubMed ID: 8807576 [TBL] [Abstract][Full Text] [Related]
14. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964 [TBL] [Abstract][Full Text] [Related]
15. High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background. Okamoto M; Takagi M; Kutsuna M; Hara Y; Nishihara M; Zhang MC; Matsuda T; Sakanaka M; Okamoto S; Nose M; Ohashi Y Clin Exp Immunol; 2004 May; 136(2):239-44. PubMed ID: 15086386 [TBL] [Abstract][Full Text] [Related]
16. Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Rordorf C; Pataki A; Nogues V; Schlager F; Feige U; Glatt M Int J Tissue React; 1987; 9(4):341-7. PubMed ID: 3623829 [TBL] [Abstract][Full Text] [Related]
18. Novel recombinant congenic mouse strain developing arthritis with enthesopathy. Mori S; Tanda N; Ito MR; Oishi H; Tsubaki T; Komori H; Zhang MC; Ono M; Nishimura M; Nose M Pathol Int; 2008 Jul; 58(7):407-14. PubMed ID: 18577108 [TBL] [Abstract][Full Text] [Related]
19. The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis. Koopman WJ; Gay S Scand J Rheumatol Suppl; 1988; 75():284-9. PubMed ID: 2467353 [TBL] [Abstract][Full Text] [Related]
20. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]